Alpa Laboratories Ltd - Stock Valuation and Financial Performance

BSE: 532878 | NSE: ALPA | Pharmaceuticals & Drugs | Small Cap

Alpa Lab Share Price

120.50 4.60 3.97%
as on 03-Dec'24 16:59

DeciZen - make an informed investing decision on Alpa Lab

Overall Rating
M-Cap below 500cr. High Risk from low Liquidity Bole Toh

1. Quality

2. Valuation

Overvalued

3. Price Trend

Semi Strong

Alpa Laboratories stock performance -

mw4me loader
P/E Ratio (SA):
11.71
Market Cap:
243.9 Cr.
52-wk low:
71
52-wk high:
144.6

Is Alpa Laboratories Ltd an attractive stock to invest in?

1. Is Alpa Laboratories Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Alpa Laboratories Ltd is a below average quality company.

2. Is Alpa Laboratories Ltd undervalued or overvalued?

The key valuation ratios of Alpa Laboratories Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Alpa Laboratories Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Alpa Laboratories Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Alpa Lab:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Alpa Laboratories Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
ROCE % -0.9%10.3%9.5%7%4.8%4.8%9.5%15.5%11.3%13.4%-
Value Creation
Index
-1.1-0.3-0.3-0.5-0.7-0.7-0.30.1-0.20.0-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 57.453.563.462.3788697.61129310997
Sales YoY Gr.--6.8%18.5%-1.8%25.2%10.2%13.5%15.1%-17.2%17%-
Adj EPS -0.33.53.32.212.32.63.75.47.79.9
YoY Gr.-NA-5.7%-33.1%-55.9%135.7%10.8%43.8%45.4%44.5%-
BVPS (₹) 41.144.846.849.150.452.455.962.6697783.1
Adj Net
Profit
-0.77.474.72.14.95.47.711.316.321
Cash Flow from Ops. -1.8-24.8-8.1-7.3-0.717.7-1.52.210.23.7-
Debt/CF from Ops. -15.6-1-1.3-0.8-2.50-0.12.70.31.4-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 7.4%6.9%3.7%17%
Adj EPS NA51.1%44.5%44.5%
BVPS7.2%8.8%11.3%11.6%
Share Price 22.8% 51.3% 27.4% 24.3%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
Return on
Equity %
-0.88.27.34.624.54.76.28.110.612.4
Op. Profit
Mgn %
4.811.711.26.71.66.98.99.58.77.510.1
Net Profit
Mgn %
-1.213.9117.52.75.75.56.912.11521.4
Debt to
Equity
0.30.30.10.10000000
Working Cap
Days
249403432356280238222224279244312
Cash Conv.
Cycle
1281461471481261068297154141256

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 12.40%

Net Profit is growing at healthy rate in last 3 years 44.54%

Sales growth has been subdued in last 3 years 3.69%

Sales growth is not so good in last 4 quarters at -14.43%

Latest Financials - Alpa Laboratories Ltd.

Standalone Consolidated
TTM EPS (₹) 9.9 9.9
TTM Sales (₹ Cr.) 97.3 97.3
BVPS (₹.) 83.1 78.2
Reserves (₹ Cr.) 154 144
P/BV 1.40 1.48
PE 11.71 11.70
From the Market
52 Week Low / High (₹) 71.00 / 144.60
All Time Low / High (₹) 5.50 / 144.60
Market Cap (₹ Cr.) 244
Equity (₹ Cr.) 21
Face Value (₹) 10
Industry PE 44.7

Management X-Ray of Alpa Lab:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Alpa Lab

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Sales5754636278869811293109
Operating Expenses 5547565877839010285101
Manufacturing Costs4334445677
Material Costs36283636495159705568
Employee Cost 87910121212121213
Other Costs 7989121513141113
Operating Profit 36741381188
Operating Profit Margin (%) 4.8%11.7%11.2%6.3%1.6%4.0%7.9%9.5%8.7%7.5%
Other Income 377553411915
Interest 2121100000
Depreciation 6111111212
Exceptional Items -10-20000000
Profit Before Tax -311975511201621
Tax -1332214534
Profit After Tax -1865347141317
PAT Margin (%) -2.4%14.5%9.4%7.7%3.8%4.7%7.4%12.6%13.6%15.4%
Adjusted EPS (₹)-0.73.72.92.31.41.93.56.76.08.0
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24

Equity and Liabilities

Shareholders Fund 879498103106110118132145162
Share Capital 21212121212121212121
Reserves 66737782858996111124141
Minority Interest0000000000
Debt2924116100414
Long Term Debt0001000210
Short Term Debt2924105100204
Trade Payables9191413131425151512
Others Liabilities 41054868141714
Total Liabilities 128147128126129130150165178192

Fixed Assets

Gross Block24252628293031343340
Accumulated Depreciation19202122232423252628
Net Fixed Assets55566679711
CWIP 0000012000
Investments 102223415968628689108
Inventories8151314141317151314
Trade Receivables24342925302535384741
Cash Equivalents 723536211610191
Others Assets9362218191217151317
Total Assets 128147128126129130150165178192

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Cash Flow From Operating Activity -2-25-8-7-118-12104
PBT -311975511201621
Adjustment 6-1-3-1-141-8-1-10
Changes in Working Capital -7-31-11-11-210-10-6-0-4
Tax Paid 1-3-3-2-2-1-3-4-4-4
Cash Flow From Investing Activity 37-71-16-15-116-161-12
Capex -10-1-2-1-3-3-2-1-6
Net Investments -10-12-3-18-12-128-150-9
Others 49664-231232
Cash Flow From Financing Activity 7-6-24-5-105-32
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing -400000020-1
Interest Paid -2-1-2-1-100000
Dividend Paid 0000000000
Others 13-4-15-4-104-33
Net Cash Flow 42-37-9-19-2054-88-6
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Ratios
ROE (%)-1.68.566.214.722.823.776.3811.349.1210.93
ROCE (%)-0.8910.349.56.984.784.839.5415.5411.3313.38
Asset Turnover Ratio0.480.420.460.490.610.660.70.710.540.59
PAT to CFO Conversion(x)N/A-3.13-1.33-1.4-0.334.5-0.140.140.770.24
Working Capital Days
Receivable Days132187183160129115112119168149
Inventory Days61728178655654525544
Payable Days9918116413697961181049972

Alpa Laboratories Ltd Stock News

Alpa Laboratories Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Alpa Lab on 03-Dec-2024 16:59 is ₹120.5.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 03-Dec-2024 16:59 the market cap of Alpa Lab stood at ₹243.9.
The latest P/E ratio of Alpa Lab as of 03-Dec-2024 16:59 is 11.71.
The latest P/B ratio of Alpa Lab as of 03-Dec-2024 16:59 is 1.40.
The 52-week high of Alpa Lab is ₹144.6 and the 52-week low is ₹71.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Alpa Lab is ₹97.30 ( Cr.) .

About Alpa Laboratories Ltd

Incorporated as Alpa Laboratories Private Limited on March 18, 1988 under the Companies Act, 1956 and converted to public limited company on September 3, 1998 with the name of Alpa Laboratories Limited. The company has been listed on the Bombay Stock Exchange and the National Stock Exchange since August 6, 2007.

Alpa Laboratories Limited is a WHO-GMP and ISO 9001:2000 certified company located at Pigdamber, about 15 kilometers from the city of Indore in Central India. The company has been manufacturing Pharmaceutical Finished Dosage Forms since 1967. With its focus on quality, the company has earned tremendous faith and confidence of its associates.

The manufacturing facility is less than 20 kilometers from the center of the city of Indore in Central India and is spread over 1.20 acres. The facility has dedicated manufacturing areas for different Finished Dosage Forms (FDFs) including liquid injections, dry injections, tablets, capsules, eye drops, ear drops, ointments, creams and gels. The production areas are designed to maximize output quality and quantity with minimal down time.

The facility is WHO-GMP certified and all manufacturing areas are supplied with independent air supply systems for individual department. The independent supply systems are fed with separate air handling units to avoid cross contamination. Pressure gradients are maintained and monitored and the required air quality of class 100, 1000, 10,000 and class 100,000 is maintained.

Business area of the company

The company manufactures a wide range of products under its own brand and for a number of other reputed Indian and multinational companies. The product range includes a wide variety of ethical, generic and over the counter (OTC) drugs in various Finished Dosage Forms for both human and veterinary use.

Products

Capsules: Equipment used for the production of hard-gelatin capsules are automatic filling machine, feeder, sorter, inspection machine and polishing machine. The filled capsules are packed in high speed automatic strip and blister packing machines suitable for various sizes. The company has the ability to produce both powder filled and granule filled capsules.

Creams, Gels & Ointments: The semi-automatic machines perform the entire process of filling, sealing & crimping of the tubes in various tube sizes of Creams, Gels, Ointments, Sterile Ophthalmic Ointments and Sterile intra-mammary infusions.

Ear & Eye Drops: This department houses sophisticated machines such as automatic sealing, capping, labeling, carton forming and wrapping machines.

Injections: The parenteral is produced in a sterile area and fed to the automatic machines for ampule or vial filling, rubber bunging and cap sealing. A similar process is used for dry powder injections.

Tablets: Rapid Mixer Granulator and Fluid Bed Dryer are used to produce the material for compression in various shapes which is carried out at various multi-station, single and double rotary tablet compression machines. There are coating machines for various types of coating of the tablets. A similar process is used for boluses.

Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.